PRESIDENTIAL Adviser for Entrepreneurship and Go Negosyo founder Joey Concepcion is now also looking forward to supporting the Breath Test from another Israel-based tech-company.
“This new testing innovation, on top of the Saliva Covid-19 testing that we initially supported, will enhance the country’s testing arsenal, keep the economy open, and help our micro, small and medium enterprises in different hard-hit sectors who are struggling the most. This will ensure that we are using all available tools to combat the spread of the disease,” Concepcion highlighted.
This pronouncement came after his exclusive meeting with SeaOil President and Chief Executive Officer Glenn Yu to explore the use of the Saliva Covid-19 Test, together with the Department of Science and Technology (DoST) headed by Sec. Fortunato Dela Pe?a, DoST-PCHRD Executive Director Dr. Jaime Montoya other public and private sector leaders.
The Breath Test, a technology developed by an Israel-based company, BioSafety Technologies Ltd can detect asymptomatic individuals as early as 1-2 days after being infected and result is available in a minute.
Backed by the Israeli Ministries of Health and Defense, BioSafety Technologies has completed its clinical test trials at five of the largest hospitals in Israel. It is collecting more statistical data from around the world, including the USA and Latin America to further improve the tests’ validity.
“We have the responsibility to ensure the safety of the Filipino people which is why we have been advocating enhanced targeted mass testing through different testing innovations. We need to help our MSMEs which serve as the backbone of our economy and which will play a major part in our national recovery. Opening the economy is the only solution, but we need to do it safely. The goal is to save jobs, lives, and livelihoods,” Concepcion said.